Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution 3.0 Unported Licence
Correction: Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9. See DOI: 10.1039/c6md00159a
Carl S.
Rye
a,
Nicola E. A.
Chessum
a,
Scott
Lamont
b,
Kurt G.
Pike
b,
Paul
Faulder
b,
Julie
Demeritt
b,
Paul
Kemmitt
b,
Julie
Tucker
b,
Lorenzo
Zani
a,
Matthew D.
Cheeseman
a,
Rosie
Isaac
b,
Louise
Goodwin
b,
Joanna
Boros
b,
Florence
Raynaud
a,
Angela
Hayes
a,
Alan T.
Henley
a,
Emmanuel
de Billy
a,
Christopher J.
Lynch
a,
Swee Y.
Sharp
a,
Robert
te Poele
a,
Lisa O’
Fee
a,
Kevin M.
Foote
b,
Stephen
Green
b,
Paul
Workman
*a and
Keith
Jones
*a
aCancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London SW7 3RP, UK. E-mail: Paul.Workman@icr.ac.uk
bAstraZeneca, Alderley Park, Macclesfield, Cheshire, SK10 4TG, UK
First published on 7th September 2016
Abstract
Correction for ‘Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9’ by Carl S. Rye et al., Med. Chem. Commun., 2016, 7, 1580–1586.
The authors regret that there was an error in the structure of compound 26 (shown in Fig. 4 of the paper). The corrected structure is shown below.
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
| This journal is © The Royal Society of Chemistry 2016 |